For years, transplant surgeons have been reluctant to use organs from people who were infected with hepatitis C, due to fears of spreading the virus. But a new study gives hope to the tens of thousands of people waiting for a transplant.
According to the study of heart and lung transplants published this week in the New England Journal of Medicine, new antiviral drugs are so effective that recipients can be protected from infection. It’s the latest in a line of studies building a case for using these organs, NPR reports.
This story was produced by Side Effects Public Media, a news collaborative covering public health.